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Abstract
Aims: To analyse the histo-morphology of cases of medullomyoblastoma and identifying its
divergent differentiation.
Methods: A retrospective review of all cases reported as medulloblastoma between the period of
Jan 2000 to Dec 2006 was carried out on Hematoxylin and eosin (H & E) stained slides. The cases
were screened on light microscopy for primitive neuroectodermal component of a
medulloblastoma accompanied by areas of "myoid" differentiation, identified on the basis of
presence of strap cells (indicating a clear skeletal muscle differentiation) and/or large anaplastic cells
with vescicular nuclei and moderate to abundant amount of eosinophilic cytoplasm. All these cases
were subjected to a panel of immunohistochemical stains, including Desmin, GFAP, NFP, HMB45,
SMA, S100, CK and EMA. Ultrastructral analysis was done on tissue obtained from paraffin blocks
in 2 cases.
Results: Male predominance (M:F = 5:1) was noted with an incidence of five percent of all cases
of medulloblastoma (6 out of 120 cases) over a period of 6 years. Primitive neuroectodermal areas
were accompanied with areas of "myoid" differentiation, 5 cases showing strap cells. Two cases
with epithelial and cartilaginous differentiation were seen. Three cases showed focal melanocytic
differentiation, identified only on HMB45 immunostaining. Four cases showed glial differentiation.
Neuronal differentiation again was very focally seen in two cases, of which one was identified only
by NFP immunostain. Seventh case is included in the study, however it is not considered to
calculate incidence as it occurred beyond the period of 6 years of records search.
Conclusion: Medullomyoblastoma is a rare childhood tumor of cerebellum. Majority of cases
reveal divergent differentiation, which are identified with the help of panel of immunostains
indicating multi-potential nature of primitive neuroectodermal cells.
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Medullomyoblastoma (MMB) is a rare cerebellar embryo-
nal neoplasm that occurs almost exclusively in children. It
has a biphasic histo-morphology, containing myoblastic
and primitive neuroectodermal components. MMB arises
exclusively in the cerebellum. English literature provides
some case reports of this rare tumor and an occasional
series of small number of cases [1-11]. In the present
series, we present histo-morphological features of 7 cases
of medullomyoblastoma and try to find out any divergent
differentiation by using a panel of immunostains.
Materials and methods
A retrospective review of all cases reported as medullob-
lastoma over the period of 6 years in the department of
Histopathology, Post graduate Institute of Medical Educa-
tion and Research (PGIMER), Chandigarh, was carried
out. Hematoxylin and eosin (H & E) stained slides as well
as paraffin blocks of all these cases were available as archi-
val material in the department. H & E slides were screened
for cases showing primitive neuroectodermal component
of a medulloblastoma accompanied by areas of "myoid"
differentiation, identified on the basis of presence of strap
cells (indicating a clear skeletal muscle differentiation)
and/or large anaplastic cells with vescicular nuclei and
moderate to abundant amount of eosinophilic cytoplasm.
Morphological details on H & E stained slides of the
selected cases were carefully noted, with a special mention
to any other differentiations accompanying the two com-
ponents of primitive neuroectodermal and rhabdomyob-
lastic cells. Sections from paraffin embedded tissues of all
these cases were subjected to a panel of immunohisto-
chemical stains, namely, Desmin, GFAP (Glial Fibrillary
Acidic Protein), NFP (Neurofilament Protein), HMB45,
SMA (Smooth Muscle Actin), S100, CK (Cytokeratin) and
EMA (Epithelial Membrane Antigen). Ultrastructural
analysis was done on tissue obtained from paraffin blocks
in 2 cases.
Results
A total of 120 cases of medulloblastoma were present in
the retrospective search of files over the period of 6 years.
A retrospective review of H & E stained slides showed 6
cases (5% of all medulloblastomas) which had morpho-
logical evidence of "myoid" differentiation accompanying
the typical areas of primitive neuroectodermal cells. Three
of these cases had been reported as medullomyoblastoma
during routine reporting. The clinicopathological data of
these cases have been summarized in Table 1. The case no.
7 that is included in the Table 1, was a previously diag-
nosed case of medullomyoblastoma, confirmed on
ultrastructural analysis in the year 1993. However this
case is beyond the period of 6 years of records search. This
case was also subjected to same panel of immunhisto-
chemical stains.
Clinical characteristics
The patients ranged in age from 3 to 28 years (median age
– 6 years). Six patients were male and one was female. The
most common presentations were headache and vomit-
ing, followed by altered sensorium, ataxia and vertigo
(Table 1). In all patients, imaging revealed a posterior
fossa space occupying lesion (SOL), involving the cerebel-
lum.
Table 1: Clinical data and histology of Medullomyoblastoma






1 28 y/M Headache, vomiting, 
ataxic gait
14 Posterior fossa SOL Predominant areas of PNE cells, nodules of cells 
showing smooth muscle differentiation, cartilaginous 
islands
2 6 mon/F Vomiting, altered 
sensorium
15 Posterior fossa SOL, 
hydrocephalus
Predominant areas of PNE cells, RMB areas present, 
focal cartilaginous and epithelial differentiation
3 4 y/M Recurrent headache, 
vomiting
20 Posterior fossa 
contrast enhancing 
SOL
Co-dominant RMB and PNE areas, many strap cells 
present
4 3 y/M Headache, vomiting, 
altered sensorium
20 Posterior fossa SOL Predominant areas of PNE cells, RMB areas present 
with strap cells
5 4 y/M Persistant vomiting 60 Posterior fossa SOL, 
hydrocephalus
Predominant areas of PNE cells, RMB areas with 
strap cells present
6 8 y/M Headache, vomiting, 
vertigo
60 Posterior fossa SOL Predominant areas comprise of larger atypical cells 
with vesicular nuclei and moderate amount of 
cytoplasm, no typical strap cells present, rest of the 
areas show PNE cells
7 4 y/M Vomiting, altered 
sensorium
30 Posterior fossa SOL Predominant areas of PNE cells, RMB areas show 
strap cells
PNE – Primitive neuroectodermal; RMB – Rhabdomyoblastic; SOL – Space occupying lesion; Age# y – years & mon-monthsPage 2 of 6
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At low power morphological features in all cases showed
undifferentiated areas comprising of primitive neuroecto-
dermal cells. These areas did not reveal definite rosette for-
mation in any of the 7 cases. All the cases except Case 6
[Table 1] had interspersed hypocellular areas which on
higher magnification showed features of rhabdomyoblas-
tic differentiation. The cells with "myoid" differentiation
had large eccentrically placed vescicular nuclei and mod-
erate amount of eosinophilic cytoplasm. Strap cells, con-
sidered to be the best morphological indicator of skeletal
muscle differentiation, were seen in all cases, except Case
1 and 6 [Table 1]. The areas with rhabdomyoblastic differ-
entiation comprised of 20 to 50% of total tumor tissue.
Case 1 [Table 1] was an extremely rare case of medullomy-
oblastoma in adult patient, aged 28 years. On histopatho-
logical examination, the tumor predominantly had
nodules of primitive neuroectodermal cells with areas of
necrosis. Another prominent finding was presence of mul-
tiple islands of cartilage located in the centre of the prim-
itive neuroectodermal nodules [Fig 1A]. Some of these
nodules showed myoid differentiation comprising of
large cells with vesicular nuclei and abundant pale cyto-
plasm. No striations however were noted in the cytoplasm
of these cells. A fascicular pattern of arrangement was
noted favouring leiomyomatous differentiation [Fig 1B].
Occasional focus however, did reveal cells with skeletal
muscle differentiation. Desmin immunostain was posi-
tive in both of these foci. Smooth muscle actin [SMA]
immunostain [Fig 2A], revealed a strong cytoplasmic pos-
itivity in the nodules confirming a smooth muscle differ-
entiation of these cells. The chondrocytes showed strong
nuclear positivity for S-100. Some of the undifferentiated
cells surrounding cartilage also showed nuclear as well as
cytoplasmic positivity with S-100. In addition focal posi-
tivity for HMB45, CK [Fig 2B], EMA, GFAP and NFP was
also noted in small round cells. EMA positivity was in
form of paranuclear dots [Fig 2C]. Overall, the tumor
revealed muscle and cartilagenous differentiation identi-
fied on morphology. Immunostaining in addition
revealed focal glial, neuronal, melanocytic and epithelial
differentiation.
Case 2 [Table 1] predominantly had typical medulloblas-
tic areas. Intervening areas of myoid differentiation were
noted although typical strap cells were not seen. In addi-
tion there were 2 foci of cartilage formation, surrounded
by the primitive neuroectodermal cells. An occasional
focus in these cellular medulloblastic areas showed epi-
thelial differentiation evidenced by the formation of
gland like structures [Fig 1C]. Immunohistochemical
staining revealed strong cytoplasmic positivity for desmin
in the areas of rhabdomyoblastic differentiation. Focal
collection of small round cells revealed a strong cytoplas-
mic granular positivity for HMB-45 indicating melano-
cytic differentiation [Fig 2D]. These cells were present in
the loose stroma intervening typical medulloblastic areas,
forming small clusters. The cells forming gland like struc-
tures revealed cytoplasmic positivity of cytokeratin. There
were no areas of necrosis. Overall this tumor showed pre-
dominant areas of primitive neuroectodermal cells and
rhabdomyoblastic areas accompanied with islands of car-
A – Areas of primitive neuroectodermal cells with islands of cartilag  (10×, HE)Figure 1
A – Areas of primitive neuroectodermal cells with islands of 
cartilage (10×, HE); B – Fascicular arrangement of spindle 
shaped cells with adjacent primitive neuroectodermal cells 
(20×, HE); C – Gland formation indicative of epithelial differ-
entiation and focal myoid cells (10×, HE); D – Primitive neur-
oectodermal cells in fibrillary background with focal 
ganglionic differentiation (20×, HE); E – Larger "atypical" 
cells, with a vescicular nuclei, prominent nucleoli and moder-
ate amount of cytoplasm (20×, HE); F – Strap cells (40×, HE); 
G – Admixture of primitive neuroectodermal cells and 
myoid differentiation of case 4 in Table 1 (10×, HE); H – 
Desmin immunostain highlighting striations in strap cells 
(40×, immunoperoxidase).Page 3 of 6
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fied on immunohistochemistry.
Case 3 [Table 1] had predominant areas of rhabdomyob-
lastic differentiation comprising of many strap cells. Rest
of the tumor had typical medulloblastic areas also accom-
panied by hypocellular fibrillary areas. Occasional neuro-
nal differentiation was noted in the form of larger cell size,
more abundant cytoplasm, vesicular nuclear chromatin
[Fig 1D]. Desmin immunostain showed strong cytoplas-
mic positivity. The positivity was also seen in few undiffer-
entiated cells adjacent to myoid areas. Coarse granular
cytoplasmic positivity of HMB-45 was seen in few cells
interspersed between nodules of primitive neuroectoder-
mal cells. The hypocellular fibrillary areas were positive
for GFAP [Fig 2E], nicely highlighting the cytoplasmic
processes of the cells with glial differentiation. Small
aggregates of cells in these fibrillary areas showed NFP
positivity [Fig 2F] indicating neuronal differentiation.
Case 6 [Table 1] was diagnosed as medulloblastoma and
did not have any areas typical of rhabdomyoblastic differ-
entiation; however, there were many larger "atypical"
cells, with a vescicular nuclei, prominent nucleoli and
moderate amount of cytoplasm, giving an epithelioid
appearance [Fig 1E]. On immunohistochemistry, most of
these atypical larger cells showed paranuclear dot positiv-
ity for desmin [Fig 2G]. A few cells also showed GFAP pos-
itivity.
Case 7 [Table 1] was diagnosed as medullomyoblastoma,
and confirmed by electron microscopy. The strap cells in
the areas of myoid differentiation, showed presence of
striations in some of these cells [Fig 1F]. Immunostains
performed revealed strong desmin positivity in strap cells
and in few cells it nicely highlighted striations in the cyto-
plasm [Fig 1H].
Case 1 and 3 [Table 1] were subjected to ultrastructural
analysis. The tissue was obtained from paraffin embedded
blocks. Both the cases showed presence of alternating thin
[actin] and thick [myosin] filaments in a parallel arrange-
ment with distinct Z-banding in several places [Fig 2H].
All these cases had a varied percentage of differentiating
cell components formed by the primitive neuroectoder-
mal cells. These were accompanied with morphologically
identifiable areas of "myoid" differentiation, 5 cases
showing strap cells, a hallmark of rhabdomyoblastic dif-
ferentiation. Two cases with epithelial and cartilaginous
differentiation were seen. Three cases, in addition,
showed focal melanocytic differentiation, identified only
on HMB45 immunostaining. Glial differentiation was
more easily picked up on H & E stained slides, in 4 out of
7 cases, by the presence of loose fibrillary areas, contain-
ing larger, differentiated cells. Neuronal differentiation
again was very focally seen in 2 cases, identified only on
NFP immunostaining. Two cases revealed only myoid dif-
ferentiation accompanying typical medulloblastoma.
Discussion
Medullomyoblastoma was described first by Marinesco
and Goldstein in 1933 [1]. Since then there has been only
A – SMA immunostain expression in the spindle cells and vessel (internal c ntrol) along with absence of xpression in primitive neuroectodermal cells (20×, immu operoxidase)Figure 2
A – SMA immunostain expression in the spindle cells and 
vessel (internal control) along with absence of expression in 
primitive neuroectodermal cells (20×, immunoperoxidase); B 
– Cytokeratin immnostain positivity (20×, immunoperoxi-
dase); C – EMA immunostain showing paranuclear dot posi-
tivity (20×, immunoperoxidase); D – HMB-45 immunostain 
showing focal cytoplasmic positivity (20×, immunoperoxi-
dase); E – GFAP immunostain positivity in glial areas (20×, 
immunoperoxidase); F – NFP immunostain positivity in few 
cells (40×, immunoperoxidase); G – Desmin immunostain 
showing paranuclear dot positivity (20×, immunoperoxidase); 
H – Ultrastructure of strap cells showing prominent Z bands 
(10000×, Uranyl acetate with lead citrate).Page 4 of 6
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an occasional case series [10,11]. We present series of 7
cases, 6 of which have been seen over a period of 6 years,
amounting to 5% of all medulloblastomas reported dur-
ing this period. The tumor was seen in early childhood,
except for one adult male patient, aged 28 years. There are
only 3 case reports of medullomyoblastoma in adults [11-
13]. This tumor showed smooth muscle, skeletal muscle
and cartilaginous differentiation accompanied with focal
melanocytic, glial, neuronal and epithelial differentia-
tions. There was a clear morphological evidence to suggest
that the primitive neuroectodermal cells are actually dif-
ferentiating into muscle and cartilaginous elements. The
other differentiations were focal and not well appreciated
on routine H & E stained slides. These were identified only
with the help of immunostains. This case also strongly
supports the idea of the multipotential nature of the prim-
itive neuroectodermal cells. There are some case reports of
differentiations in a medulloblastoma other than muscle
and these include melanocytic, cartilaginous and epithe-
lial differentiations [6,14,15]. In addition, melanocytic
rhabdomyomedulloblastomas have also been rarely
reported [16]. In the present series a panel of immunos-
tains has established the presence of varied differentia-
tions which accompany the myoid differentiation in
medullomyoblastoma. There were 2 cases [Case 1 and
Case 4, Table 1] which had accompanying cartilaginous
islands. Both of these cases showed focal epithelial and
melanocytic differentiations. The pattern of desmin
immnostaining has also been of interest, as in most of the
cases it showed diffuse cytoplasmic positivity, except in
Case 6 [Table 2], where it was seen as a paranuclear dot
and in Case 7 [Table 2], the immunostain highlighted
cytoplasmic striations in the strap cells.
A differential diagnosis in such cases of posterior fossa
tumor is an atypical teratoid/rhabdoid tumor [AT/RT].
However, this is mostly seen in early infancy and preferen-
tially located in cerebellar hemispheres, rather than aris-
ing from vermis. Histologically, the tumor cells are
polygonal with abundant eosinophilic cytoplasm and
eccentric nuclei and on immunostaining, these cells are
variably positive for desmin, vimentin, GFAP, CK, EMA,
SMA and synaptophysin [17].
Medullomyoblastomas, have been treated by a combina-
tion of surgery and/or chemotherapy and/or radiotherapy
[10]. Most of the cases reported in the literature had a
poor outcome. Three out of 6 cases, reported by Helton et
al, died of the disease within 2 years [10]. One patient,
however, remained free of disease for above 15 years, fol-
lowing treatment of a recurrence. Another case report of
medullomyoblastoma in the literature has mentioned a
long survival for over 11 years without recurrence [18]. All
patients in our series underwent partial or total tumor
resection with radiotherapy and/or chemotherapy. Most
of the patients were lost to follow up at varied time inter-
vals and hence the data on follow up remains unsatisfac-
tory.
Present series of medullomyoblastoma identifies it to be a
tumor of early childhood, with only one exceptional case
presenting in adulthood. There is also a clear male pre-
dominance [M:F = 6:1]. Five percent of all cases of medul-
loblastoma [6/120], over a period of 6 years, showed
myoid differentiation, the incidence being higher than in
the series by Helton et al, which reported it to be about
3% of all patients of medulloblastoma [10]. The cases in
our series showed a variety of differentiations; including
cartilaginous, epithelial, glial, neuronal, melanocytic dif-
ferentiations, most identified only on immunohisto-
chemistry. Hence, this study also highlights the
multipotential nature of primitive neuroectodermal cells
of medulloblastoma and utility of these immunostains in
highlighting the divergent differentiation.
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